Summary
In a significant market movement during November 2021, LoQus23 Therapeutics was the subject of a vc funding. The transaction achieved a gross valuation of £7,000,000. Leading the round was Dementia Discovery Fund, Novartis Venture Fund.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Dementia Discovery Fund
Lead Investor / Acquirer
Novartis Venture Fund
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Seed prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in